Skip to main content
Atrás
OPCH logo

Option Care Health, Inc.

Calidad de datos: 100%
Sobreventa
OPCH
NASDAQ Healthcare Medical - Care Facilities
$28.41
$0.00 (0.00%)
Cap. Mercado: 4.51B
Rango del Día
$28.27 $28.87
Rango de 52 Semanas
$24.24 $36.80
Volumen
1,472,730
Promedio 50D / 200D
$33.13 / $30.45
Cierre Anterior
$28.41

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (627 pares)

Métrica Acción Mediana del Sector
P/E 21.7 0.4
P/B 3.4 2.9
ROE % 15.2 3.9
Net Margin % 3.7 3.8
Rev Growth 5Y % 13.2 10.0
D/E 0.0 0.2

Precio Objetivo de Analistas

Hold
$38.14 +34.2%
Low: $35.00 High: $42.00
P/E Futuro
15.2
EPS Futuro
$1.87
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
5.9 B

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2030 $2.85
$2.80 – $2.90
 8.3 B 1
FY2029 $2.58
$2.54 – $2.62
 7.7 B 1
FY2028 $2.44
$2.44 – $2.45
 7 B 3

Puntos Clave

Revenue grew 13.22% annually over 5 years — strong growth
ROE of 15.20% — decent returns on equity
Debt/Equity of 0.00 — conservative balance sheet
Generating 258.45M in free cash flow
Cash machine — converts 124.50% of earnings into free cash flow
Capital efficient — spends only 0.00% of revenue on capex

Crecimiento

Revenue Growth (5Y)
13.22%
Revenue (1Y)13.03%
Earnings (1Y)-2.00%
FCF Growth (3Y)-11.43%

Calidad

Return on Equity
15.20%
ROIC19.11%
Net Margin3.67%
Op. Margin5.98%

Seguridad

Debt / Equity
0.00
Current Ratio1.53
Interest Coverage2.70

Valoración

P/E Ratio
21.72
P/B Ratio3.40
EV/EBITDA12.66
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 13.03% Revenue Growth (3Y) 14.59%
Earnings Growth (1Y) -2.00% Earnings Growth (3Y) -11.84%
Revenue Growth (5Y) 13.22% Earnings Growth (5Y) 10.37%
Profitability
Revenue (TTM) 5.65B Net Income (TTM) 207.59M
ROE 15.20% ROA 6.01%
Gross Margin 19.26% Operating Margin 5.98%
Net Margin 3.67% Free Cash Flow (TTM) 258.45M
ROIC 19.11% FCF Growth (3Y) -11.43%
Safety
Debt / Equity 0.00 Current Ratio 1.53
Interest Coverage 2.70 Dividend Yield 0.00%
Valuation
P/E Ratio 21.72 P/B Ratio 3.40
P/S Ratio 0.80 PEG Ratio 5.98
EV/EBITDA 12.66 Dividend Yield 0.00%
Market Cap 4.51B Enterprise Value 4.28B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.65B 5.00B 4.30B 3.94B 3.44B
Net Income 207.59M 211.82M 267.09M 150.56M 139.90M
EPS (Diluted) 1.28 1.23 1.48 0.83 0.77
Gross Profit 1.09B 1.01B 981.22M 866.92M 779.61M
Operating Income 337.91M 321.83M 314.60M 240.23M 190.84M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.46B 3.42B 3.33B 3.23B 2.93B
Total Liabilities 2.13B 2.02B 1.91B 1.85B 1.75B
Shareholders' Equity 1.33B 1.40B 1.42B 1.39B 1.18B
Total Debt 0.0 1.22B 1.17B 1.16B 1.16B
Cash & Equivalents 232.62M 412.57M 343.85M 294.19M 119.42M
Current Assets 1.26B 1.32B 1.09B 994.34M 710.26M
Current Liabilities 829.35M 780.15M 618.31M 565.35M 459.70M

Puntuaciones de Estrategias

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#996 of 1052
19
Growth Price/Sales Ratio Focus (Ken Fisher)
#369 of 618
30

Actividad Reciente

Entró Cash Flow Compounder
Mar 24, 2026
Entró Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026